从总体和报告或假设的相对负担估计中计算子组疾病负担的公式
Kwame Owusu-Edusei1, Arijita Deb2, Elamin H Elbasha1
1Merck & Co., Inc., Rahway, NJ, USA.
Dialogues in health
|May 9, 2025
概括
新的公式允许使用总体估计计算特定人口子组的疾病负担. 这解决了为公共卫生研究和干预获得子组特定数据的挑战.
科学领域:
- 公共卫生 公共卫生
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 疾病的风险和负担在不同的人口子组之间有很大差异.
- 准确的子组数据对于有效的公共卫生规划和干预至关重要.
- 目前的研究往往缺乏详细的亚种群数据,这阻碍了精确的分析.
研究的目的:
- 为计算特定亚组的疾病负担 (发病率,流行率,成本) 求出公式.
- 从总人口估计和相对估计中提供估计子人口数据的方法.
主要方法:
- 在多个子组中推导用于计算负担的符号公式.
- 用数值示例说明方法的说明.
- 应用统计方法来估计不确定性分析的置信区间.
主要成果:
- 公式允许通过调整总负担与相对子组负担比例来计算子组负担.
- 该方法可扩展到任意数量的子组 (n).
- 可以计算置信区间来考虑数据的不确定性.
结论:
- 衍生式可以提高亚组疾病负担估计的准确性.
- 这种方法有助于减轻健康研究,干预计划和政策分析中的错误.
- 通过提供必要的子组数据,促进更精确的公共卫生决策.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Probability Laws
38.3K
Overview
38.3K
Relative Risk
96
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
96
Comparing the Survival Analysis of Two or More Groups
90
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
90
Hazard Ratio
71
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
71
Odds Ratio
81
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
81


